Terms ending in 2041
Every in-force patent on Amgen Inc.'s record whose computed term ends in 2041, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,104,995 | Systems and Methods for Performing a Real-Time Assay of a Sample In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 11,887,302 | Systems and Methods for Detecting Cytopathic Effect in Cells In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 12,251,474 | Process for Lyophilized Pharmaceutical Formulations of a Therapeutic Protein In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 12,318,593 | Hydraulic-Pneumatic Pressurized Chamber Drug Delivery System In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 11,854,779 | Systems and Methods for Reducing Lab-To-Lab And/Or Instrument-To-Instrument Variability of Multi-Attribute Method (MAM) by Run-Time Signal Intensity Calibrations In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 12,078,701 | Methods of Fingerprinting Therapeutic Proteins via a Two-Dimensional (2D) Nuclear Magnetic Resonance Technique at Natural Abundance for Formulated Biopharmaceutical Products In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 11,518,808 | Anti-PD-1 Antibodies and Methods of Treatment In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 12,257,343 | Excipients to Reduce the Viscosity of Antibody Formulations and Formulation Compositions In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 12,012,462 | Chimeric Receptors to DLL3 and Methods of Use Thereof In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 12,000,775 | System Suitability Method for Use with Protein Concentration Determination by Slope In force · High confidence | Amgen Inc. | In force | High confidence | |
| 55 more term ends in 2041 · Pro | |||||
10 of 65 patents shown. Soonest term end first, then patent number.
Pro members see all 65.
61 of these are in force and held by Amgen Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.